8:00 AM – 8:20 AM
Opening Remarks
Ciprian Tomuleasa MD
11 years of Insights in Hematology
8:20 AM – 10:00 AM
Stem Cell Biology
Moderator: Jose Cancelas & Mick Milsom
8:20 – 8:40
April 15th
Gabriel Ghiaur
Clonal Hematopoiesis, a tale of two stem cells
Johns Hopkins, Baltimore, MD, USA
8:40 – 9:00
April 15th
Nina Cabezas Wallscheid
Metabolic regulation of hematopoiesis stem cells upon aging
ETH Zürich, Zürich, Switzerland
9:00 – 9:20
April 15th
Hartmut Geiger
Intracellular complement factor C3 and hematopoietic stem cell priming
University of Ulm, Ulm, Germany
9:20 – 9:40
April 15th
Michael Milsom
Is hematologic aging driven by HSC dysfunction
German Cancer Research Center (DKFZ), Heidelberg, Germany
9:40 – 10:00
April 15th
Jose A. Cancelas
Adipokines Mediate Hematopoietic Regeneration and Stem Cell Fitness
Dana-Farber Cancer Institute | Harvard Medical School, Boston, MA, USA
10:00 AM – 12:10 PM
MDS / MPN
Moderator: Valeria Santini MD
10:00 – 10:20
April 15th
Valeria Santini, MD
Therapeutic options in MDS/MPN vs MDS
University of Florence, Firenze, Italy
10:20 – 10:40
April 15th
Sanam Loghavi, MD
Oligomonocytic CMML: Fact or Fiction? Redefining the Boundaries Between MDS and CMML
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
10:40 – 11:00
April 15th
Mrinal S. Patnaik, M.B.B.S.
Targeting RAS pathway mutations in myeloproliferative CMML and myelodysplastic syndrome/MPN overlap neoplasms
Mayo Clinic, Rochester, MN, USA
11:00 – 11:20
April 15th
Moshe Mittelman MD
MDS diagnosis: Beyond the bone marrow and blast count — The digital and genomic revolution
Chairman, Israel Cancer Association · Chairman, Scientific Board, European LeukemiaNet – MDS Foundation · Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
11:20 – 11:50
April 15th
Coffee Break
11:50 – 12:10
April 15th
Johnson & Johnson Symposium
Ioana Codruta Rus MD
Chasing Functional Cure in NDMM: MRD- Driven Frontline Therapy and Maintenance
Hematologist, "Prof. Dr. Ion Chiricuță" Oncology Institute, Cluj-Napoca
12:10 – 12:30
April 15th
AstraZeneca Symposium
Ioana Codruta Rus MD
Paroxysmal Nocturnal Haemoglobinuria: symptoms - diagnosis - treatment
Hematologist, "Prof. Dr. Ion Chiricuță" Oncology Institute, Cluj-Napoca
12:30 – 12:50
April 15th
Roche Symposium
12:50 – 2:00
April 15th
Lunch Break
2:00 PM – 7:00 PM
CLL, Lymphoma & Myeloma
Moderator: Ciprian Tomuleasa MD
2:00 – 3:00
April 15th
Genesis Pharma Symposiums
Updates in the management of Hematological Rare Diseases
Moderator: Ciprian Tomuleasa MD
2:00 – 2:20
Anamaria Bancos MD
Acute Hepatic Porphyria - From scientific evidence to clinical experience
Hematologist, Clinical County Emergency Hospital Bistrița, Bistrița-Năsăud
2:20 – 2:40
Ioana Codruta Rus MD
A new perspective in the management of hATTR Amyloidosis
Hematologist, "Prof. Dr. Ion Chiricuță" Oncology Institute, Cluj-Napoca
2:40 – 3:00
Sabina Iluta MD
Quizartinib in the management of Acute Myeloid Leukaemia (AML) FLT3-ITD positive
Hematologist, Clinical County Emergency Hospital Bistrița, Bistrița-Năsăud
3:00 – 3:20
April 15th
Anna Schuh, MD
Oxford Molecular Diagnostics Centre, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
3:20 – 3:30
April 15th
Coffee Break
3:30 – 4:00
April 15th
Lilly Symposium
4:00 – 4:20
April 15th
Joshua Brandstadter, MD
University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
4:20 – 4:30
April 15th
Coffee Break
4:30 – 4:50
April 15th
Pfizer Symposium
Mihnea Zdrenghea MD
Optimization of Treatment in RRMM: The Role and Importance of ELREXFIO (Elranatamab)
Department of Hematology – Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
4:50 – 5:05
April 15th
Swixx BioPharma Symposium
5:05 – 5:25
April 15th
Antonio Maraver, PhD
Notch pathway, from development to T-ALL and beyond
Institut de Recherche en Cancérologie de Montpellier, Montpellier, France
5:25 – 5:45
April 15th
Antonio Vitale, MD
University of Siena, Italy
5:45 – 6:00
April 15th
Coffee Break
6:00 – 6:30
April 15th
Sobi Symposium
6:30 – 7:00
April 15th
Amgen Symposium
Mihnea Zdrenghea MD
Blincyto: a new standard in consolidation therapy for newly diagnosed Ph- negative B-ALL
Department of Hematology – Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
